ClinicalTrials.gov record
Completed Phase 3 Interventional

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

ClinicalTrials.gov ID: NCT00046904

Public ClinicalTrials.gov record NCT00046904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Placebo-Controlled, Randomized, Double-Blind Comparison Of Etanercept (Enbrel) Versus Placebo For The Treatment Of Cancer-Associated Weight Loss And Anorexia

Study identification

NCT ID
NCT00046904
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mayo Clinic
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • etanercept Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Aug 31, 2007
Completion
Not listed
Last update posted
May 4, 2011

Started 2003

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
MBCCOP - Gulf Coast Mobile Alabama 36607
Mayo Clinic Scottsdale Scottsdale Arizona 85259
Mayo Clinic - Jacksonville Jacksonville Florida 32224
MBCCOP - Hawaii Honolulu Hawaii 96813
CCOP - Illinois Oncology Research Association Peoria Illinois 61615-7828
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1854
Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106
Mayo Clinic Cancer Center Rochester Minnesota 55905
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106
Cancer Care Center at Medcenter One Hospital Bismarck North Dakota 58501-5505
CCOP - Oklahoma Tulsa Oklahoma 74136
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
CCOP - Upstate Carolina Spartanburg South Carolina 29303
Rapid City Regional Hospital Rapid City South Dakota 57709
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2011 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00046904 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →